Related Experiment Video

Updated: Jul 4, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Clinical and pharmacological management of a high risk diabetic population undergoing percutaneous coronary

S Delcré1, M Anselmino, C Moretti

  • 1Cardiology Unit, San Giovanni Battista-Molinette Hospital, University of Turin, Turin, Italy.

Minerva Cardioangiologica
|May 30, 2008
PubMed

Insights

Optimal management of diabetes mellitus (DM) and coronary artery disease (CAD) is crucial. This study found suboptimal guideline adherence in DM patients post-percutaneous coronary intervention, necessitating improved clinical care to reduce cardiovascular events.

Area of Science:

  • Cardiology
  • Endocrinology
  • Clinical Medicine

Background:

  • Optimal management of patients with diabetes mellitus (DM) and coronary artery disease (CAD) is essential for reducing cardiovascular events.
  • Percutaneous coronary intervention (PCI) is a common procedure for CAD, and its outcomes in diabetic patients require careful monitoring.
  • Adherence to current guidelines for DM management in CAD patients undergoing PCI is critical for patient prognosis.

Purpose of the Study:

  • To assess the adherence to the latest guidelines for managing diabetes mellitus in patients undergoing percutaneous coronary intervention.
  • To stratify DM patients based on their diabetes management quality after PCI.
  • To identify areas for improvement in the clinical care of diabetic patients with coronary artery disease.

Main Methods:

  • A cohort of consecutive type 2 DM patients undergoing balloon angioplasty with stent implantation were followed.
  • Data collected included sociodemographic details, medical history, pharmaceutical treatment, and major adverse cardiac and cerebrovascular events.
  • Clinical variables assessed quality of DM management, monitoring, and adherence to guidelines over a mean follow-up of 39 months.

Main Results:

  • Despite high risk, 36% of patients received insulin with poor glycemic control (HbA1c >7% in 59%).
  • Clinical management was unsatisfactory: only 41% achieved HbA1c targets, 36% blood pressure targets, and 22% BMI targets.
  • Strict guideline adherence was observed in only 26% of patients; 36% were severely distant from recommendations.

Conclusions:

  • The quality of diabetes mellitus management requires significant improvement to reduce high cardiovascular event rates in patients with coronary artery disease.
  • Current clinical practices fall short of recommended guidelines for managing diabetic patients undergoing PCI.
  • Enhanced clinical strategies are imperative to optimize outcomes for this high-risk patient population.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...